BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.05 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAIQ) Return on Assets [ROA] (2018 - 2026)

Updated

BioXcel Therapeutics (BTAIQ) recorded Return on Assets [ROA] of -194.99% in Q2 2026, up 10.99 percentage points from -205.99% a year earlier but down 25.81 percentage points from the prior quarter.

Analysis

BioXcel Therapeutics (BTAIQ) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For FY2025, BioXcel Therapeutics reported Return on Assets [ROA] of -159.46%, down 17.06 percentage points from FY2024.

  • Annual Return on Assets [ROA] has declined for four straight years, with a five-year change of -95.35 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -142.40% in FY2024 (-14.02 pp), -128.38% in FY2023 (-54.12 pp), -74.26% in FY2022 (-27.70 pp) and -46.55% in FY2021 (+17.56 pp).
  • Quarterly Return on Assets [ROA] has ranged from -206.08% in Q4 2023 to -37.57% in Q3 2021 over the past five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased for three consecutive quarters, with an average year-over-year change of +5.20 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 34.91 percentage points in Q4 2025, against a drop of 132.71 percentage points in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -169.18% (Q1 2026), -147.99% (Q4 2025) and -187.53% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 BioXcel Therapeutics 1.57 Mn 1.57 Mn 160,000.00 -194.99%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -194.99%
Mar 31, 2026 -169.18%
Dec 31, 2025 -147.99%
Sep 30, 2025 -187.53%
Jun 30, 2025 -205.99%
Mar 31, 2025 -173.62%
Dec 31, 2024 -182.90%
Sep 30, 2024 -153.91%
Jun 30, 2024 -162.42%
Mar 31, 2024 -197.05%
Dec 31, 2023 -206.08%
Sep 30, 2023 -175.78%
Jun 30, 2023 -126.67%
Mar 31, 2023 -96.60%
Dec 31, 2022 -73.37%
Sep 30, 2022 -55.63%
Jun 30, 2022 -53.16%
Mar 31, 2022 -49.74%
Dec 31, 2021 -42.71%
Sep 30, 2021 -37.57%
API Access

BioXcel Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY